Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA) (Q57281927)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA)	scientific article

Statements

scholarly article

0 references

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial (English)

0 references

0 references

0 references

object named as

Mark Caulfield

6

0 references

Sverre E. Kjeldsen

8

object named as

Sverre E Kjeldsen

0 references

author name string

Peter S Sever

1

Imperial College London

0 references

Björn Dahlöf

2

0 references

Neil R Poulter

3

0 references

Hans Wedel

4

0 references

Gareth Beevers

5

0 references

Rory Collins

7

0 references

Arni Kristinsson

9

0 references

Gordon T McInnes

10

0 references

Jesper Mehlsen

11

0 references

Markku Nieminen

12

0 references

Eoin O'Brien

13

0 references

Jan Östergren

14

0 references

publication date

2004

0 references

0 references

64

0 references

Supplement 2

0 references

43-60

0 references

https://scigraph.springernature.com/pub.10.2165/00003495-200464002-00005

0 references

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current perspectives on statins

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review on the risk and benefit of different cholesterol-lowering interventions

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15765890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200464002-00005

0 references

10.2165/00003495-200464002-00005

0 references

Dimensions Publication ID

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57281927&oldid=1547634819"